Related Articles
Tanshinone IIA potentiates the efficacy of 5-FU in Colo205 colon cancer cells in vivo through downregulation of P-gp and LC3-II
STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma
Cucurbitacin B inhibits cell proliferation and induces apoptosis in human osteosarcoma cells via modulation of the JAK2/STAT3 and MAPK pathways
MicroRNA-155 promotes the proliferation and invasion abilities of colon cancer cells by targeting quaking
The anticancer effects of Cucurbitacin I inhibited cell growth of human non‑small cell lung cancer through PI3K/AKT/p70S6K pathway